Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Clinicobiological, immunophenotypic, and molecular characteristics of monoclonal CD56-/+dim chronic natural killer cell large granular lymphocytosis.

Lima M, Almeida J, Montero AG, Teixeira Mdos A, Queirós ML, Santos AH, Balanzategui A, Estevinho A, Algueró Mdel C, Barcena P, Fonseca S, Amorim ML, Cabeda JM, Pinho L, Gonzalez M, San Miguel J, Justiça B, Orfão A.

Am J Pathol. 2004 Oct;165(4):1117-27.

2.

Extranodal NK/T cell lymphoma and aggressive NK cell leukaemia: evidence for their origin on CD56+bright CD16-/+dim NK cells.

Lima M.

Pathology. 2015 Oct;47(6):503-14. doi: 10.1097/PAT.0000000000000275. Review.

PMID:
26166665
3.

Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm.

Chan JK, Sin VC, Wong KF, Ng CS, Tsang WY, Chan CH, Cheung MM, Lau WH.

Blood. 1997 Jun 15;89(12):4501-13. Review.

4.

Role of chemokines in the biology of natural killer cells.

Maghazachi AA.

Curr Top Microbiol Immunol. 2010;341:37-58. doi: 10.1007/82_2010_20. Review.

PMID:
20369317
5.

The biology of human natural killer-cell subsets.

Cooper MA, Fehniger TA, Caligiuri MA.

Trends Immunol. 2001 Nov;22(11):633-40. Review.

PMID:
11698225
6.

CD56bright natural killer (NK) cells: an important NK cell subset.

Poli A, Michel T, Thérésine M, Andrès E, Hentges F, Zimmer J.

Immunology. 2009 Apr;126(4):458-65. doi: 10.1111/j.1365-2567.2008.03027.x. Review.

7.

Human Circulating and Tissue-Resident CD56(bright) Natural Killer Cell Populations.

Melsen JE, Lugthart G, Lankester AC, Schilham MW.

Front Immunol. 2016 Jun 30;7:262. doi: 10.3389/fimmu.2016.00262. eCollection 2016. Review.

8.

Features of Memory-Like and PD-1(+) Human NK Cell Subsets.

Della Chiesa M, Pesce S, Muccio L, Carlomagno S, Sivori S, Moretta A, Marcenaro E.

Front Immunol. 2016 Sep 14;7:351. doi: 10.3389/fimmu.2016.00351. eCollection 2016. Review.

9.

Abnormal expansions of granular lymphocytes: reactive lymphocytosis or chronic leukemia? Case report and literature review.

Gastl G, Rumpold H, Kraft D, Gattringer C, Schuler G, Margreiter R, Schmalzl F, Huber C.

Blut. 1986 Feb;52(2):73-89. Review.

PMID:
2936412
10.

Human NK Cell Subsets in Pregnancy and Disease: Toward a New Biological Complexity.

Cristiani CM, Palella E, Sottile R, Tallerico R, Garofalo C, Carbone E.

Front Immunol. 2016 Dec 27;7:656. doi: 10.3389/fimmu.2016.00656. eCollection 2016. Review.

11.

Indolent T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: a review and update.

Matnani R, Ganapathi KA, Lewis SK, Green PH, Alobeid B, Bhagat G.

Hematol Oncol. 2017 Mar;35(1):3-16. doi: 10.1002/hon.2317. Epub 2016 Jun 29. Review.

PMID:
27353398
12.

Immunological and Translational Aspects of NK Cell-Based Antitumor Immunotherapies.

Shevtsov M, Multhoff G.

Front Immunol. 2016 Nov 11;7:492. eCollection 2016. Review.

13.

Functional Significance of CD57 Expression on Human NK Cells and Relevance to Disease.

Nielsen CM, White MJ, Goodier MR, Riley EM.

Front Immunol. 2013 Dec 9;4:422. doi: 10.3389/fimmu.2013.00422. Review.

14.

Historical overview on the morphological characterization of large granular lymphocytes/natural killer cells.

Ribatti D.

Immunol Lett. 2017 Jul 27;190:58-63. doi: 10.1016/j.imlet.2017.07.014. [Epub ahead of print] Review.

PMID:
28757130

Supplemental Content

Support Center